RecruitingNot ApplicableNCT07281118

Intercostal Cryoanalgesia in Double Lung Transplant Recipients


Sponsor

University of California, Los Angeles

Enrollment

148 participants

Start Date

Dec 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Adults ≥18 years of age
  • Undergoing double lung transplantation via bilateral thoracotomies or clamshell incision

Exclusion Criteria2

  • Multi-organ transplant recipients
  • Redo lung transplant recipients

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAtricure CryoSPHERE MAX Probe

Patients will be treated intra-operatively with Atricure CryoSPHERE MAX Probe to 2 intercostal spaces above and below the thoracotomy incision for 1 minutes for each application during their double lung transplant procedure.


Locations(3)

University of California Los Angeles

Los Angeles, California, United States

University of California San Francisco

San Francisco, California, United States

Baylor University

Waco, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07281118


Related Trials